4/18
02:12 pm
vigl
Vigil Neuroscience, Inc. (NASDAQ: VIGL) had its "market outperform" rating re-affirmed by analysts at JMP Securities. They now have a $23.00 price target on the stock.
Medium
Report
Vigil Neuroscience, Inc. (NASDAQ: VIGL) had its "market outperform" rating re-affirmed by analysts at JMP Securities. They now have a $23.00 price target on the stock.
4/17
04:19 pm
vigl
Vigil Presents Key Findings from ILLUMINATE & IGNITE Studies in ALSP at the 2024 American Academy of Neurology Annual Meeting [Yahoo! Finance]
Medium
Report
Vigil Presents Key Findings from ILLUMINATE & IGNITE Studies in ALSP at the 2024 American Academy of Neurology Annual Meeting [Yahoo! Finance]
4/17
04:05 pm
vigl
Vigil Presents Key Findings from ILLUMINATE & IGNITE Studies in ALSP at the 2024 American Academy of Neurology Annual Meeting
Medium
Report
Vigil Presents Key Findings from ILLUMINATE & IGNITE Studies in ALSP at the 2024 American Academy of Neurology Annual Meeting
3/27
10:08 am
vigl
Vigil Neuroscience, Inc. (NASDAQ: VIGL) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $24.00 price target on the stock.
Medium
Report
Vigil Neuroscience, Inc. (NASDAQ: VIGL) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $24.00 price target on the stock.
3/26
07:14 am
vigl
Vigil Neuroscience Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update [Yahoo! Finance]
Medium
Report
Vigil Neuroscience Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update [Yahoo! Finance]
3/26
07:05 am
vigl
Vigil Neuroscience Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
Medium
Report
Vigil Neuroscience Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
3/24
09:53 am
vigl
Is Vigil Neuroscience (NASDAQ:VIGL) In A Good Position To Deliver On Growth Plans? [Yahoo! Finance]
Medium
Report
Is Vigil Neuroscience (NASDAQ:VIGL) In A Good Position To Deliver On Growth Plans? [Yahoo! Finance]
3/20
07:12 am
vigl
Vigil Neuroscience Appoints Petra Kaufmann, M.D., as Chief Medical Officer [Yahoo! Finance]
Medium
Report
Vigil Neuroscience Appoints Petra Kaufmann, M.D., as Chief Medical Officer [Yahoo! Finance]
3/20
07:05 am
vigl
Vigil Neuroscience Appoints Petra Kaufmann, M.D., as Chief Medical Officer
Medium
Report
Vigil Neuroscience Appoints Petra Kaufmann, M.D., as Chief Medical Officer
3/13
07:05 am
vigl
Vigil Announces Upcoming Presentations at 2024 American Academy of Neurology Annual Meeting
Low
Report
Vigil Announces Upcoming Presentations at 2024 American Academy of Neurology Annual Meeting
3/12
07:05 am
vigl
Vigil Neuroscience to Present at Stifel 2024 Virtual CNS Days
Medium
Report
Vigil Neuroscience to Present at Stifel 2024 Virtual CNS Days
3/6
04:36 pm
vigl
Vigil Announces Oral Presentation on Small Molecule TREM2 Agonist VG-3927 as a Potential Disease-Modifying Therapeutic at AD/PD 2024 [Yahoo! Finance]
Medium
Report
Vigil Announces Oral Presentation on Small Molecule TREM2 Agonist VG-3927 as a Potential Disease-Modifying Therapeutic at AD/PD 2024 [Yahoo! Finance]
3/6
04:25 pm
vigl
Vigil Announces Oral Presentation on Small Molecule TREM2 Agonist VG-3927 as a Potential Disease-Modifying Therapeutic at AD/PD 2024
Medium
Report
Vigil Announces Oral Presentation on Small Molecule TREM2 Agonist VG-3927 as a Potential Disease-Modifying Therapeutic at AD/PD 2024
2/29
04:26 pm
vigl
Vigil Presents Poster on Impacts of Misdiagnosis and Genetic Testing on Adult-Onset Leukoencephalopathy with Axonal Spheroids and Pigmented Glia (ALSP) Patient Journey at ACTRIMS 2024 [Yahoo! Finance]
Low
Report
Vigil Presents Poster on Impacts of Misdiagnosis and Genetic Testing on Adult-Onset Leukoencephalopathy with Axonal Spheroids and Pigmented Glia (ALSP) Patient Journey at ACTRIMS 2024 [Yahoo! Finance]
2/29
04:05 pm
vigl
Vigil Presents Poster on Impacts of Misdiagnosis and Genetic Testing on Adult-Onset Leukoencephalopathy with Axonal Spheroids and Pigmented Glia (ALSP) Patient Journey at ACTRIMS 2024
Low
Report
Vigil Presents Poster on Impacts of Misdiagnosis and Genetic Testing on Adult-Onset Leukoencephalopathy with Axonal Spheroids and Pigmented Glia (ALSP) Patient Journey at ACTRIMS 2024
2/8
08:18 am
vigl
Acrivon Therapeutics Appoints Seasoned Industry Executive Ivana Magovcevic-Liebisch, Ph.D., J.D., to Board of Directors [Yahoo! Finance]
Low
Report
Acrivon Therapeutics Appoints Seasoned Industry Executive Ivana Magovcevic-Liebisch, Ph.D., J.D., to Board of Directors [Yahoo! Finance]
2/7
04:05 pm
vigl
Vigil Neuroscience to Present at Guggenheim 6th Annual Biotechnology Conference
Low
Report
Vigil Neuroscience to Present at Guggenheim 6th Annual Biotechnology Conference